2238 

110 / 11. 8 ~ 11. 14

 

臨床藥學大觀園

《論藥之道》

Lixiana® (Edoxaban) 用於心房顫動之劑量調整(下)

 

 

◎文╱陳柏瑋

 

檢驗項目參考值


BUN (blood urea nitrogen): 7-20 mg/dL; SCr (serum creatinine): male: 0.7-1.5 mg/dL; female: 0.5-1.2 mg/dL; CCr (Creatinine clearance rate): >60 mL/min; ALT (alanine aminotransferase): 0-40 U/L; AST (aspartate aminotransferase): 5-45 U/L


(全文完)


參考資料


1. Jan Steffel, Ronan Collins, Matthias Antz, et al. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace 2021;00:1-65.
2. Robert P Giugliano , Christian T Ruff, Eugene Braunwald, et al. Edoxaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2013;369:2093-104.


(本文作者為臺北榮民總醫院藥學部臨床藥師 / 陽明大學藥理所碩士)

 

回首頁